Reference
Stergiopoulos S, et al. Adverse Drug Reaction Case Safety Practices in Large Biopharmaceutical Organizations from 2007 to 2017: An Industry Survey. Pharmaceutical Medicine 33: 499-510, No. 6, Dec 2019. Available from: URL: https://doi.org/10.1007/s40290-019-00307-x
Rights and permissions
About this article
Cite this article
Changes in ADR reporting in large biopharmaceutical companies. Reactions Weekly 1783, 10 (2019). https://doi.org/10.1007/s40278-019-72493-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-72493-2